Eli Lilly's new drug Inluriyo has been approved by the FDA for the treatment of late-stage breast cancer.

According to the Securities Times Finance app, Eli Lilly (LLY.US) announced on Thursday that its new drug for adult patients with advanced breast cancer who have previously been treated has been approved by the US Food and Drug Administration (FDA).